Summit Therapeutics (SMMT.MX) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-14.18
-9.79
-5.4
-1.01

Details

Expected EPS
-1.6942436532000003
Actual EPS
-14.178864
Surprise EPS
-12.48
Surprise Percent
+736.88%

Description

Summit Therapeutics (SMMT.MX) has reported earnings of -14.178864 per share for Q3 2025.

0 Comments

Share your thoughts